A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio Introduces Bill to Combat Illegal Sale of Fentanyl, Other Drugs Online
Washington, D.C. — U.S. Senators Marco Rubio (R-FL) and Amy Klobuchar (D-MN) introduced the Domain Reform for Unlawful Drug Sellers (DRUGS) Act (S. 3399) to provide the U.S. Food and Drug Administration (FDA) the authority to suspend websites run by criminal networks that traffic fentanyl, counterfeit medications, and other illegal drugs. The bill, based on a successful pilot program from the FDA and the National Telecommunications and Information Administration, would require registries and registrars to lock those domain names, identified by trusted notifiers, as facilitating the sale of illicit drugs and then suspend them. The bill provides for an appeals process to allow legitimate online pharmacies to demonstrate they are operating legally and safely. A one-pager of the legislation is available here.
“Florida ranks second in the nation for overdose deaths, and far too many families across the country find themselves torn apart by drug addiction,” Rubio said. “We need to crack down on bad actors, including those from China, that target our youth and families with the online sales of counterfeit and illicit drugs like fentanyl. Without legislative action, this highly addictive drug will continue to fuel the growing opioid crisis in America. I encourage my colleagues to support this bill and give our communities the protection they need.”
“The opioid epidemic is hurting communities across our nation—none have been immune to its devastating effects,” Klobuchar said. “This bipartisan legislation will help eliminate unlawful digital pharmacies and other marketplaces illegally selling opioids or substandard drugs online, a major step as we work to address this public health emergency. Moving forward, I’ll keep pushing for policies to stop illegal sale of opioids and assist families impacted by this epidemic.”
The DRUGS Act has been endorsed by the Alliance for Safe Online Pharmacies, the National Association of Boards of Pharmacy, the National Consumers League, RESOLVE: The National Infertility Association, the International Federation of Pharmaceutical Wholesalers, the Coalition for Online Accountability, the Partnership for Safe Medicines, and the Pharmaceutical Security Institute.